Metabolic Dysfunction-Associated Steatotic Liver Disease and Outcomes in Atrial Fibrillation.
- DOI
- 10.1016/j.amjmed.2026.08.030
- Published
- 2026 Sep 17
- Container
- The American journal of medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.amjmed.2026.08.030,
title = {Metabolic Dysfunction-Associated Steatotic Liver Disease and Outcomes in Atrial Fibrillation.},
author = {Danpanichkul P and Pang Y and Duangsonk K and Sivakumar N and Tothanarungroj P and Anouti A and Souza M and Mousa OY and Cotter TG and Kim D and Liangpunsakul S and Krittanawong C and Noureddin M},
year = {2026},
journal = {The American journal of medicine},
doi = {10.1016/j.amjmed.2026.08.030},
url = {https://doi.org/10.1016/j.amjmed.2026.08.030}
}RIS
TY - JOUR TI - Metabolic Dysfunction-Associated Steatotic Liver Disease and Outcomes in Atrial Fibrillation. AU - Danpanichkul P AU - Pang Y AU - Duangsonk K AU - Sivakumar N AU - Tothanarungroj P AU - Anouti A AU - Souza M AU - Mousa OY AU - Cotter TG AU - Kim D AU - Liangpunsakul S AU - Krittanawong C AU - Noureddin M PY - 2026 JO - The American journal of medicine DO - 10.1016/j.amjmed.2026.08.030 UR - https://doi.org/10.1016/j.amjmed.2026.08.030 ER -
APA
P, D., Y, P., K, D., N, S., P, T., A, A., M, S., OY, M., TG, C., D, K., S, L., C, K., & M, N. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease and Outcomes in Atrial Fibrillation.. The American journal of medicine. https://doi.org/10.1016/j.amjmed.2026.08.030
Source records
- pubmed · retrieved 2026-09-25T20:59:27.332Z